Zhang XZ - Search Results

1

Valproic acid as a promising agent to combat Alzheimer's disease.

Zhang XZ, Li XJ, Zhang HY. Zhang XZ, et al. Among authors: zhang hy. Brain Res Bull. 2010 Jan 15;81(1):3-6. doi: 10.1016/j.brainresbull.2009.09.003. Brain Res Bull. 2010. PMID: 19748552 Review.

2

Impact of drug discovery on stem cell biology.

Zhang XZ, Li XJ, Ji HF, Zhang HY. Zhang XZ, et al. Among authors: zhang hy. Biochem Biophys Res Commun. 2009 Jun 5;383(3):275-9. doi: 10.1016/j.bbrc.2009.04.026. Epub 2009 Apr 12. Biochem Biophys Res Commun. 2009. PMID: 19366619 Review.

3

Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes.

Quan Y, Liu MY, Liu YM, Zhu LD, Wu YS, Luo ZH, Zhang XZ, Xu SZ, Yang QY, Zhang HY. Quan Y, et al. Among authors: zhang xz, zhang hy. Molecules. 2018 Mar 23;23(4):736. doi: 10.3390/molecules23040736. Molecules. 2018. PMID: 29570606 Free PMC article.

4

Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.

Zhang XZ, Wang L, Liu DW, Tang GY, Zhang HY. Zhang XZ, et al. Among authors: zhang hy. J Med Food. 2014 Sep;17(9):955-62. doi: 10.1089/jmf.2013.2967. Epub 2014 Jul 21. J Med Food. 2014. PMID: 25045784 Free PMC article.

5

Medical genetics-based drug repurposing for Alzheimer's disease.

Zhang XZ, Quan Y, Tang GY. Zhang XZ, et al. Brain Res Bull. 2015 Jan;110:26-9. doi: 10.1016/j.brainresbull.2014.11.003. Epub 2014 Nov 22. Brain Res Bull. 2015. PMID: 25446738 Review.

6

Curcumin's potential to modulate stem cell fate.

Zhang XZ, Li XJ, Zhang HY. Zhang XZ, et al. Among authors: zhang hy. Trends Pharmacol Sci. 2009 Jul;30(7):331-2. doi: 10.1016/j.tips.2009.04.003. Epub 2009 Jun 10. Trends Pharmacol Sci. 2009. PMID: 19523693 No abstract available.

7

Salvia miltiorrhiza: A source for anti-Alzheimer's disease drugs.

Zhang XZ, Qian SS, Zhang YJ, Wang RQ. Zhang XZ, et al. Among authors: zhang yj. Pharm Biol. 2016;54(1):18-24. doi: 10.3109/13880209.2015.1027408. Epub 2015 Apr 10. Pharm Biol. 2016. PMID: 25857808 Review.

8

Synergistic Activity of an Antimetabolite Drug and Tyrosine Kinase Inhibitors against Breast Cancer Cells.

Wu Y, Zhang D, Wu B, Quan Y, Liu D, Li Y, Zhang X. Wu Y, et al. Chem Pharm Bull (Tokyo). 2017 Aug 1;65(8):768-775. doi: 10.1248/cpb.c17-00261. Epub 2017 May 25. Chem Pharm Bull (Tokyo). 2017. PMID: 28539531 Free article.

9

Effect of norcantharidin on the human breast cancer Bcap-37 cells.

Liu D, Shi P, Yin X, Chen Z, Zhang X. Liu D, et al. Connect Tissue Res. 2012;53(6):508-12. doi: 10.3109/03008207.2012.694928. Epub 2012 Jul 20. Connect Tissue Res. 2012. PMID: 22606958

10

Synergistic Inhibition of Breast Cancer Cell Growth by an Epigenome-Targeting Drug and a Tyrosine Kinase Inhibitor.

Wu YS, Quan Y, Zhang DX, Liu DW, Zhang XZ. Wu YS, et al. Among authors: zhang dx, zhang xz. Biol Pharm Bull. 2017;40(10):1747-1753. doi: 10.1248/bpb.b17-00360. Biol Pharm Bull. 2017. PMID: 28966246 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,259 results

Search Page